| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.07B | — | +5.8% |
| Cost of Revenue | $471.3M | — | +12.5% |
| R&D Expense | $141.6M | — | +14.6% |
| SG&A Expense | $163.8M | — | +5.1% |
| Operating Income | $114.5M | — | -25.9% |
| Interest Expense | $8.3M | — | +22.3% |
| Pre-tax Income | $122.0M | — | -29.6% |
| Income Tax | $15.7M | — | -68.8% |
| Net Income | $106.3M | — | -13.7% |
| EPS (Basic) | $0.73 | — | -12.0% |
| EPS (Diluted) | $0.71 | — | -13.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $622.4M | -33.1% | -43.3% |
| Short-term Investments | $308.1M | +20.2% | +37.4% |
| Accounts Receivable | $881.1M | +11.0% | +16.0% |
| Current Assets | $2.13B | -6.8% | -10.3% |
| Total Assets | $11.65B | +1.4% | +16.7% |
| Current Liabilities | $1.04B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $312.5M | — | +24.4% |
| Capital Expenditures | $101.7M | — | -13.7% |
| Investing Cash Flow | -$319.5M | — | -136.4% |
| Financing Cash Flow | -$291.7M | — | +47.2% |
| Free Cash Flow | $210.8M | — | +58.0% |
| -48.6% |
| Total Liabilities | $6.74B | +3.6% | +24.8% |
| Stockholders' Equity | $4.91B | -1.4% | +7.1% |